Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).
This page lists clinical trials related to Acne from the ClinicalTrials.gov database.
Trial Summary
- Total studies: 50
- Recruiting: 12
- Active, not recruiting: 10
- Completed: 15
- Other: 13
Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.
Recruiting Trials
NCT02996656 — Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Université de Montréal |
| Enrollment | 88 |
| Study Type | INTERVENTIONAL |
| Conditions | Propionibacterium Infection |
| Interventions | ; |
INESS Antibiotic Prophylaxis in Orthopedic Guide recommends the use of Cefazolin at induction for all orthopaedic procedure with implantation of internal fixation device. With the increasing rate of identified P. acnes shoulder surgery infection despite the use of recommended skin preparation and preoperative prophylactic antibiotics, a question arises; Is Cefazolin the most effective prophylac…
NCT06316297 — Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
| Status | Recruiting |
| Phase | Phase 1 / Phase 2 |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Enrollment | 800 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne |
| Interventions | ; |
The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to four dose levels in adult participants aged 18 to 45 years with moderate to severe acne.
This trial will consist of a Core Study followed by an optional Long-Term Extension (LTE).
The Core Study will consist of:
- Two cohorts evaluati…
NCT05902221 — Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Enrollment | 235 |
| Study Type | INTERVENTIONAL |
| Conditions | Infections Joint Prosthetic |
| Interventions | ; |
Cutibacterium acnes is involved in nearly 40% of shoulder prosthetic joint infections (PJI). After shoulder prothesis, C. acnes mainly affects hip prosthesis. One recent work from the Lyon (France) bone and joint infections reference center with data focusing mainly on hip and knee PJI has reported that C. acnes is the leading cause of late-onset PJI after coagulase negative staphylococci (CNS)…
NCT07659769 — Global Healthcare Study on Hidradenitis Suppurativa
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Julia Tatjana Maul |
| Enrollment | 9600 |
| Study Type | OBSERVATIONAL |
| Conditions | Hidradenitis Suppurativa (HS); Hidradenitis Suppurativa (Acne Inversa) |
The Global Healthcare Study on Hidradenitis Suppurativa (GHSHS) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with psoriasis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare deliver…
NCT06225570 — Weekly Isotretinoin vs Tetracycline for Moderate Acne
| Status | Recruiting |
| Phase | Early Phase 1 |
| Sponsor | Medical University of South Carolina |
| Enrollment | 50 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions | ; |
In the effort to find better treatments for Moderate Acne, which often relies on long-term antibiotic use, researchers are exploring alternative options. While Isotretinoin, a Vitamin A derivative, is highly effective for severe acne, its side effects limit its use for milder cases. A recent study from our institution investigated a new approach: weekly Isotretinoin dosing. The results were pro…
NCT06447480 — Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Enrollment | 420 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions | ; |
In Dermatology, assessment of people of color remains underrepresented in RCTs (<10%) and guidelines. Acne affects around 9% of the population worldwide and negatively affects quality of life and self-esteem with anxiety, suicidal ideation and physical scarring. Main lesions associate comedons, inflammatory papules and pustules which grading of severity allows decision-making, e.g., topicals i…
NCT06989840 — Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | Sagimet Biosciences Inc. |
| Enrollment | 128 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne |
| Interventions | ; |
This is a 4-part study. Part A will be a randomized, double-blind, placebo-controlled investigation of single ascending doses (SAD) to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) biomarkers of TVB-3567 administered orally in healthy participants. Part B will be a randomized, open-label, 2-way crossover investigation to assess the effect of food on a single d…
NCT07547956 — Subcision With Injection of Poly Deoxyribonucleotide Versus Subcision With Injection of Non-cross Linked Hyaluronic Acid in Rolling Acne Scars Treatment.
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Cairo University |
| Enrollment | 20 |
| Study Type | INTERVENTIONAL |
| Conditions | Atrophic Acne Scars |
| Interventions |
The aim of this study is to evaluate and compare the efficacy and safety of two different injectable agents combined with subcision for treating rolling acne scars. In this split-face clinical trial, each participant will receive subcision on both sides of the face. One side will then be treated with an injection of Polydeoxyribonucleotide (PDRN), while the other side will receive an injection …
NCT07287644 — A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
| Status | Recruiting |
| Phase | Phase 2 / Phase 3 |
| Sponsor | Bluefin Biomedicine, Inc. |
| Enrollment | 210 |
| Study Type | INTERVENTIONAL |
| Conditions | Hidradenitis Suppurativa (HS) |
| Interventions | ; |
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
NCT07213973 — Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Incyte Corporation |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | Hidradenitis Suppurativa (HS) |
| Interventions |
The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradenitis suppurativa over a 54-week open-label treatment period.
NCT07544251 — Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Integrative Skin Science and Research |
| Enrollment | 30 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions | ; |
This study is being done to help better understand how the gut and skin bacteria of the body change when people with acne are treated with Sarecycline or Doxycycline. The bacteria in the gut and on the skin will be studied to see how each treatment may affect them and whether they change the profile of the bacteria that is present.
NCT07341087 — Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial
| Status | Recruiting |
| Phase | N/A |
| Sponsor | King’s College London |
| Enrollment | 30 |
| Study Type | INTERVENTIONAL |
| Conditions | Skin Inflammation; Immunosenescence; Inflammation; Skin Health; Eczema |
| Interventions | ; |
This study will explore whether a daily probiotic drink containing Lactobacillus casei Shirota (LcS) can help improve immune function and reduce inflammation in women going through the menopausal transition. Hormonal changes during this stage of life can affect the immune system, gut health, and skin, sometimes leading to increased inflammation or conditions such as eczema, acne or rosacea.
Pa…
Active, Not Recruiting
NCT01976260 — A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Sponsor | Northwestern University |
| Enrollment | 16 |
| Study Type | INTERVENTIONAL |
| Conditions | Cicatrix |
| Interventions | ; |
The purpose of this study is to compare the effectiveness of the ePrime fractional radiofrequency system to the 1550-nm fractional photothermolysis system (Fraxel) in the ability to improve acne scar appearance.
NCT04901195 — A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Sponsor | UCB Biopharma SRL |
| Enrollment | 658 |
| Study Type | INTERVENTIONAL |
| Conditions | Hidradenitis Suppurativa |
| Interventions |
The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)
NCT04582383 — Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
| Status | Active, not recruiting |
| Phase | Phase 4 |
| Sponsor | University of Pennsylvania |
| Enrollment | 350 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne |
| Interventions | ; |
Acne is common illness of adolescents and young adults which is associated with substantial morbidity. While topical treatments are often sufficient for mild acne, moderate to severe acne often requires treatment with systemic medications such as oral antibiotics, hormonal therapies such spironolactone, and isotretinoin. Sebum overproduction is fundamental to the pathogenesis of acne with assoc…
NCT05995340 — ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Sponsor | AbbVie |
| Enrollment | 157 |
| Study Type | INTERVENTIONAL |
| Conditions | Atrophic Acne Scars |
| Interventions | ; |
Visit the study website https://dawnacnescarstudy.com/ACT for more information. Atrophic acne scars are flat, indented or with an inverted center scars that develop at the endpoint of the normal healing process for acne. Acne scarring that remains after acne resolves has a significant impact on health related quality of life, including reduced self-esteem and embarrassment/self consciousness. E…
NCT05891795 — Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
| Status | Active, not recruiting |
| Phase | Phase 1 / Phase 2 |
| Sponsor | Stanford University |
| Enrollment | 18 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions | ; |
Mechanism-based acne treatment for transgender patients receiving testosterone currently does not exist and is an unmet medical need. This study explores clascoterone to treat testosterone induced acne. Many treatments we use to treat acne in females cannot be used in transgender males because they interfere with hormone therapy. Androgens have been associated with the development of acne vulga…
NCT06799000 — A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Sponsor | Novartis Pharmaceuticals |
| Enrollment | 588 |
| Study Type | INTERVENTIONAL |
| Conditions | Hidradenitis Suppurativa |
| Interventions | ; ; |
The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS).
NCT06840392 — A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Sponsor | Novartis Pharmaceuticals |
| Enrollment | 565 |
| Study Type | INTERVENTIONAL |
| Conditions | Hidradenitis Suppurativa |
| Interventions | ; ; |
The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS).
NCT07368764 — The Suitability of Tience® for Treating Acne Scars
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | Linio Biotech Oy |
| Enrollment | 20 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne; Acne Scars |
| Interventions |
This is an open-label, single-center, split-face, pseudo-randomized clinical trial designed to evaluate the efficacy and safety of a human-derived, cell-free adipose tissue derivative (Tience® ), for treating moderate to severe acne scars. Participants will receive three treatment sessions over a three-month period: on Day 0, Day 30, and Day 90. Treatment will be administered via injections to …
NCT06993610 — Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Sponsor | Zura Bio Inc |
| Enrollment | 225 |
| Study Type | INTERVENTIONAL |
| Conditions | Hidradenitis Suppurativa (HS) |
| Interventions | ; ; |
The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, followed by a 16-week open-label extension period in which all participants will receive tibulizumab (Period 2)
NCT07036302 — Comparative Effects Of Trichloroacetic Chemical Peel And Fractional Laser
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | Jose Roberto Cortelli |
| Enrollment | 120 |
| Study Type | INTERVENTIONAL |
| Conditions | Melasma; Acne Scars - Mixed Atrophic and Hypertrophic; Resurfacing; Rejuvenation |
| Interventions | ; ; |
More than aesthetics, the search for orofacial harmonization treatments has increased when the negative emotional impact of some facial conditions such as melasma and acne scars is recognized. This study will evaluate the effects of chemical peels with 35% TCA (trichloroacetic acid) and two types of fractional laser in orofacial harmonization procedures. A sample of 100-120 participants at leas…
Not Yet Recruiting
NCT07524946 — Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
| Status | Not yet recruiting |
| Phase | Phase 4 |
| Sponsor | Bausch Health Americas, Inc. |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions |
This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris.
NCT07549828 — Sebum Metabolomics and Lipidomics for Clinical Applications
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | National Taiwan University Hospital |
| Enrollment | 200 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne; Atopic Dermatitis; Seborrheic Dermatitis; Psoriasis; Healthy Subjects (HS) |
| Interventions | ; |
This study aims to develop a standardized workflow for sebum sampling and metabolomics/lipidomics analysis using Sebutape. A total of 200 participants will be recruited, including healthy individuals, patients with skin diseases, individuals undergoing dermatological treatments or using skincare products, and a subset of healthy participants receiving short-term topical antibiotic intervention….
NCT07583121 — Impact of a Daily Application of an Omega-3 Monoglycerides Based Serum and Cream on the Skin Microbiota
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | SCF Pharma |
| Enrollment | 10 |
| Study Type | INTERVENTIONAL |
| Conditions | Eczema |
| Interventions |
This exploratory study aims to investigate the prebiotic potential of daily application of an omega-3 serum and cream to skin affected by eczema. The study will also collect data on any potential adverse effects of the products. Ten subjects will be enrolled in the study and will receive the same treatment for fourteen days. Their baseline condition before treatment will serve as a control for …
NCT07620769 — Safety and Efficacy Evaluation of the Radiofrequency Therapeutic Device for the Treatment of Atrophic Acne Scars
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | CLASSYS Inc. |
| Enrollment | 252 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Scars; Acne Scars - Atrophic; Acne Scar; Acne Scarring |
| Interventions | ; ; |
The objective of this clinical trial is to evaluate the safety and effectiveness of a radiofrequency treatment device for the treatment of atrophic acne scars.
This is a prospective, multicenter, randomized, parallel-controlled, blinded-assessment, non-inferiority trial design.
The study aims to evaluate the effectiveness and safety of the radiofrequency therapeutic device manufactured by Spo…
NCT07127523 — A Clinical Trial to Investigate the Efficacy and Safety of GenLabs’ Social Renew on Improving Acne Symptoms and Skin Repair Among Healthy Adults
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | GenCanna Acquisition Corp |
| Enrollment | 150 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne |
| Interventions | ; |
The goal of this interventional clinical trial is to investigate the efficacy and safety of GenLabs’ Social Renew on improving acne symptoms and skin repair among healthy adults. The main question[s] it aims to answer is:
What is the difference in the change in acne symptoms as assessed by the Acne Quality of Life Questionnaire (ACNE-QoL) between GenLabs’ Social Renew and placebo from baseli…
NCT07639073 — Low-Dose Versus Conventional-Dose Oral Isotretinoin for Acne Vulgaris
| Status | Not yet recruiting |
| Phase | Phase 4 |
| Sponsor | Pakistan Institute of Medical Sciences |
| Enrollment | 164 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions |
Background and Purpose:
Acne vulgaris is a common skin condition that can cause significant physical and emotional distress. Oral isotretinoin is a highly effective treatment for severe or persistent acne. While the standard (conventional) dose is effective, it is often associated with side effects like dry skin, chapped lips, and altered labs.
The purpose of this study is to compare a lower …
NCT07089368 — Photodynamic Therapy With Topical Application of a Zn(II) Phthalocyanine (RLP068/Cl) and Red Light for the Treatment of Moderate-to-severe Acne Vulgaris
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Università degli Studi di Brescia |
| Enrollment | 10 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne |
| Interventions |
This pilot clinical study will evaluate the safety, tolerability, and effectiveness of a novel photodynamic therapy (PDT) for moderate-to-severe acne vulgaris. PDT combines a topical photosensitizing gel with red light to treat acne lesions. The gel to be used in this study, called RLP068/Cl (a zinc phthalocyanine compound), has demonstrated antimicrobial, anti-inflammatory, and sebosuppressive…
NCT07673094 — Comparison of Topical Clascoterone and Adapalene for Mild Acne Vulgaris
| Status | Not yet recruiting |
| Phase | Early Phase 1 |
| Sponsor | Khyber Teaching Hospital |
| Enrollment | 60 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions | ; |
There is no local data available regarding the comparative efficacy of topical clascoterone and topical adapalene, particularly in patients with mild acne vulgaris. The findings of this study will help dermatologists identify the more effective topical treatment for mild acne vulgaris, leading to improved patient outcomes and better utilization of healthcare resources. Furthermore, the study wi…
NCT07481019 — A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | National University Hospital, Singapore |
| Enrollment | 250 |
| Study Type | INTERVENTIONAL |
| Conditions | Chronic Dermatological Conditions; Eczema; Urticaria; Psoriasis; Acne |
| Interventions | ; |
The goal of this clinical trial is to evaluate whether an electronic patient-reported outcome measure (ePROM)-guided flexible scheduling system can improve outpatient clinic resource utilisation in patients attending dermatology outpatient clinics for routine follow-up. The main questions it aims to answer are:
- Does the intervention reduce the number of actualised outpatient visits over 12 m…
NCT07539129 — Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Foundation University Islamabad |
| Enrollment | 64 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions | ; |
This randomized controlled trial evaluates the efficacy of oral probiotics compared to placebo in Pakistani patients with moderate Acne Vulgaris. Acne is a multifactorial inflammatory disorder influenced by microbial colonization, seborrhea, and immune dysregulation. Rising antibiotic resistance necessitates alternative therapeutic approaches. Emerging evidence highlights the gut-skin axis, sug…
NCT06992154 — Role of Akkermansia Muciniphila in Acne Vulgaris
| Status | Not yet recruiting |
| Phase | Early Phase 1 |
| Sponsor | Medical University of South Carolina |
| Enrollment | 34 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne |
| Interventions |
The project explores the use of Pendulum’s Glucose Control, which contains a unique combination of probiotics, including Akkermansia muciniphila, Clostridium beijerinckii, Anaerobutyricum hallii, Clostridium butyricum, and Bifidobacterium infantis, to treat acne by improving gut health and reducing inflammation. These probiotic strains work synergistically to enhance the gut’s protective barrie…
Completed Trials
NCT01696513 — Effect of Subcision and Suction on Acne Scars
| Status | Completed |
| Phase | N/A |
| Sponsor | Northwestern University |
| Enrollment | 20 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Scars |
| Interventions | ; |
The primary objective of this study is to determine whether the use of standard treatment in conjunction with suction will improve acne scars compared to a standard treatment alone.
NCT02216864 — Effect of Multiple Subcisions on Rolling Acne Scars
| Status | Completed |
| Phase | N/A |
| Sponsor | Northwestern University |
| Enrollment | 5 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Scars |
| Interventions |
The purpose of this study is to find out whether the use of multiple subcisions over several visits will improve the appearance of rolling acne scars compared to no treatment.
This study was a pilot study designed to determine feasibility of this procedure.
NCT04242446 — A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
| Status | Completed |
| Phase | Phase 3 |
| Sponsor | UCB Biopharma SRL |
| Enrollment | 505 |
| Study Type | INTERVENTIONAL |
| Conditions | Hidradenitis Suppurativa |
| Interventions | ; |
The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)
NCT04242498 — A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
| Status | Completed |
| Phase | Phase 3 |
| Sponsor | UCB Biopharma SRL |
| Enrollment | 509 |
| Study Type | INTERVENTIONAL |
| Conditions | Hidradenitis Suppurativa |
| Interventions | ; |
The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)
NCT05080764 — Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
| Status | Completed |
| Phase | Phase 2 |
| Sponsor | Biofrontera Inc. |
| Enrollment | 120 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions | ; ; |
The aim of this study is to test the safety and efficacy of photodynamic therapy (PDT) for the medication Ameluz® performed with the PDT-lamp BF-RhodoLED® in comparison to the respective placebo treatment for moderate to severe Acne vulgaris.
NCT06338046 — SMosE Safety and Efficacy Evaluation as a Skin Adaptogen
| Status | Completed |
| Phase | N/A |
| Sponsor | Federico II University |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | Sebum Production; Acne Scars; Skin Barrier to Water Loss |
| Interventions | ; |
This study evaluates the biological activity, safety, and clinical efficacy of SMosE (Shiitake Mushroom Oil-Soluble Extract), a topical cosmetic ingredient developed to support skin barrier function, adaptogenic responses, and sebum balance.
The investigation integrates preclinical in vitro studies, ex vivo human skin explant experiments, and a randomized, double-blind, placebo-controlled clin…
NCT06415279 — A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients
| Status | Completed |
| Phase | Phase 4 |
| Sponsor | Sun Pharmaceutical Industries Limited |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions |
The etiology of acne is heavily dependent on the production of sebum by the sebaceous glands that results in the growth of the bacteria c. acnes. If no sebum is present, there is no nutritional source for the c. acnes, the bacteria die, and acne resolves. An FDA approved acne medication consisting of clascoterone cream 1% is believed to effectively treat acne due to a decrease in sebum producti…
NCT06141330 — Vitamin D Supplementation in Acne
| Status | Completed |
| Phase | N/A |
| Sponsor | HITEC-Institute of Medical Sciences |
| Enrollment | 58 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions | ; ; |
The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is:
• To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone.
Participants will receive vit…
NCT07675460 — Systemic Isotretinoin Therapy and Eye
| Status | Completed |
| Phase | N/A |
| Sponsor | Demet Mutlu |
| Enrollment | 60 |
| Study Type | INTERVENTIONAL |
| Conditions | Dry Eye; Choroidal Thickness; Retinal Vascularisation; Acne Cystic; Isotretinoin |
| Interventions |
The dermatologist created a treatment plan for participants diagnosed with acne using medications containing vitamin A. While this medication has many benefits for the skin, it also has various side effects affecting many other systems. One of the most important of these side effects is related to the eyes. Therefore, the dermatologist will refer participants to an eye clinic for eye exams befo…
NCT06513182 — Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?
| Status | Completed |
| Phase | N/A |
| Sponsor | University of Utah |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Cutibacterium Acnes |
| Interventions | ; |
Prosthetic joint infection is a devastating complication of shoulder arthroplasty. A relatively novel method of preventing PJI has been with the use of a wound protection device. There is minimal investigative research on the use of a wound protector in shoulder arthroplasty, specifically with an ability to decrease wound contamination. The investigators primary purpose of the proposed study is…
NCT06603077 — A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa
| Status | Completed |
| Phase | Phase 2 |
| Sponsor | Avalo Therapeutics, Inc. |
| Enrollment | 253 |
| Study Type | INTERVENTIONAL |
| Conditions | Hidradenitis Suppurativa |
| Interventions | ; ; |
The main purpose of this study is to evaluate the efficacy and safety of AVTX-009 compared with placebo in patients with moderate to severe Hidradenitis Suppurativa (HS).
NCT07572331 — Clinical Study Evaluating the Safety and Effectiveness of the NIRA Laser M2.1 for the Treatment of Full-Face Wrinkles
| Status | Completed |
| Phase | N/A |
| Sponsor | NIRA Innovations Inc. |
| Enrollment | 120 |
| Study Type | INTERVENTIONAL |
| Conditions | Skin Ageing; Facial Wrinkles; Acne; Skin Elasticity; Infraorbital Dark Circle Severity |
| Interventions | ; |
This clinical trial evaluated the safety and effectiveness of the NIRA Laser M2.1, with or without a topical treatment, for the treatment of full-face wrinkles in adults. Participants were assigned to one of two treatment arms: laser-only treatment or laser treatment followed by topical treatment. Wrinkle improvement was assessed using standardized facial photographs reviewed by blinded evaluat…
NCT07510295 — Efficacy of Human UC-MSC-derived Exosomes and BM-MSC-derived Exosomes for Atrophic Acne Scar
| Status | Completed |
| Phase | N/A |
| Sponsor | Ngô Anh Tuấn |
| Enrollment | 22 |
| Study Type | INTERVENTIONAL |
| Conditions | Atrophic Acne Scars |
| Interventions | ; |
The goal of this clinical trial is to learn if exosomes from human umbilical cord and bone marrow can improve atrophic acne scars when used after fractional CO₂ laser treatment in adults.
The main questions it aims to answer are:
- Do exosomes improve acne scars more than standard treatment alone?
- Are exosomes safe when used after laser treatment? Researchers will compare one side of the fa…
NCT07244887 — Randomized, Triple-Blind, Vehicle-Controlled Trial of Topical Dapsone Gel 7.5% in Patients With Acne Vulgaris
| Status | Completed |
| Phase | Phase 4 |
| Sponsor | Oya Helin Dundar |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions | ; |
The goal of this randomized, triple-blind, vehicle-controlled clinical trial is to evaluate whether topical 7.5% dapsone gel is effective for treating mild-to-moderate acne vulgaris in adults.
The main questions are:
- Does dapsone gel improve global acne severity compared with a matched vehicle gel?
- Does dapsone gel improve comedonal and papulopustular acne severity?
- Does dapsone gel red…
NCT07652112 — AI-Generated Acne Vulgaris Learning Material Study
| Status | Completed |
| Phase | N/A |
| Sponsor | Hasan Durmuş |
| Enrollment | 190 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris; Medical Education |
| Interventions | ; |
This comparative educational intervention study evaluated the educational effectiveness of artificial intelligence-generated patient information material on acne vulgaris among early-year medical students. In the first phase, acne vulgaris information texts were generated using different artificial intelligence models and evaluated by two dermatologists using quality and understandability asses…
Other (Terminated)
NCT04466527 — Laser Treatment of Moderate to Severe Acne Vulgaris
| Status | Terminated |
| Phase | N/A |
| Sponsor | Massachusetts General Hospital |
| Enrollment | 4 |
| Study Type | INTERVENTIONAL |
| Conditions | Acne Vulgaris |
| Interventions |
The goal of this clinical trial is to learn if fractional ablative laser can treat active acne vulgaris in adults 18 to 40 years old with moderate to severe acne vulgaris.
The main questions it aims to answer are:
Does ablative fractional carbon dioxide treatment effectively treat moderate to severe active nodular acne vulgaris?
Does ablative fractional carbon dioxide treatment effectively t…
NCT06155513 — Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema
| Status | Terminated |
| Phase | N/A |
| Sponsor | SCF Pharma |
| Enrollment | 7 |
| Study Type | INTERVENTIONAL |
| Conditions | Eczema |
| Interventions | ; |
This exploratory study aims to verify the impact on the severity of eczema as well as the prebiotic potential of a daily application of Omega-3 serum and cream on a skin with eczema. This study will also collect data on possible adverse effects of the products. Sixteen participants will be enrolled in this study and will be divided in two groups of 8 subjects that will receive two different tre…